Super Session 7 - Where now for Alzheimers? 
Thursday, September 15, 2016
•
S8
•
9:45 AM
>
10:45 AM
•
Super Session 7 - Where now for Alzheimers?
•
Plenary Room A3
Co-Hosted by Nansen Neuroscience Network and Boehringer Ingelheim
Neuroscience and particularly Alzheimer’s disease has not only proven to be one of the most challenging areas for finding treatments, it is also one of the diseases putting the greatest burden on society. Current treatment will only temporarily improve symptoms, but are there new treatments around the corner potentially stopping or significantly delaying the progression of the disease? International experts will share their views on what we can realistically expect in the near future.
Moderator: Prof. Tormod Fladby, Chairman, Nansen Neuroscience Network
Speakers:
Dr. Klaus Mendla, Global Head, CNS Business Development and Licensing, Boehringer Ingelheim
Dr. Christer Nordstedt, Vice President and Head CNS Research and Clinical Investigation, Eli Lilly and Company
Prof. Lars Lannfelt, Department of Public Health and Caring Sciences/Geriatrics, Uppsala University
Dr. Ingrid Teigland Akay, Managing Partner, Hadean Ventures
|